Opportunities for early therapy of respiratory syncytial virus (RSV) infection: what happens before hospitalization

被引:6
作者
DeVincenzo, JP
Aitken, JB
Harrison, LG
机构
[1] Univ Tennessee, Dept Pediat, Memphis, TN 38103 USA
[2] Childrens Fdn Res Ctr, Memphis, TN 38103 USA
[3] Lebonheur Childrens Hosp & Med Ctr, Virol Lab, Memphis, TN USA
[4] Methodist Lebonheur Mol Diagnost Lab, Memphis, TN USA
关键词
respiratory syncytial virus; antiviral; therapy; bronchiolitis; infant;
D O I
10.1016/j.antiviral.2003.12.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
RSV loads of infants are already declining near the time of hospitalization. For optimal effect, antiviral and other RSV therapeutics therefore may need to be applied before this occurs. 134 RSV-hospitalized infants were studied to determine the timing of events and their healthcare seeking behavior prior to hospitalization. Sixty-two percent of infants had contact with a health care professional greater than or equal to1 day prior to hospitalization and 46% had such a contact on greater than or equal to2 different days prior to hospitalization. The mean (S.D.) duration of RSV symptoms prior to hospitalization was 3.9 +/- 2.3 days and prior to first health care contact was 2.6 +/- 1.8 days. RSV-hospitalized infants routinely have contact with health care professionals at significantly early time points in their illness. These contacts are potential opportunities for initiation of early anti-RSV therapy. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 15 条
  • [1] Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
    Boyce, TG
    Mellen, BG
    Mitchel, EF
    Wright, PF
    Griffin, MR
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (06) : 865 - 870
  • [2] Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants
    Buckingham, SC
    Bush, AJ
    Devincenzo, JP
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (02) : 113 - 117
  • [3] A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: Effects on RSV quantity and clinical outcome
    Buckingham, SC
    Jafri, HS
    Bush, AJ
    Carubelli, CM
    Sheeran, P
    Hardy, RD
    Ottolini, MG
    Ramilo, O
    DeVincenzo, JP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09) : 1222 - 1228
  • [4] DEVINCENZO J, 2001, PEDIAT RES, V1352
  • [5] Therapy of respiratory syncytial virus infection
    Devincenzo, JP
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (08) : 786 - 790
  • [6] Relationship between respiratory syncytial virus load and illness severity in children
    DeVincenzo, JP
    Buckingham, SC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (09) : 1376 - 1377
  • [7] DEVINCENZO JP, 2003, 43 ANN INT C ANT AG
  • [8] FISHMAN AP, 1997, LUNG BIOL HEALTH DIS, V99, P1
  • [9] Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999
    Leader, S
    Kohlhase, K
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (07) : 629 - 632
  • [10] Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein
    Malley, R
    DeVincenzo, J
    Ramilo, O
    Dennehy, PH
    Meissner, HC
    Gruber, WC
    Sanchez, PJ
    Jafri, H
    Balsley, J
    Carlin, D
    Buckingham, S
    Vernacchio, L
    Ambrosino, DM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) : 1555 - 1561